Integro Medical Clinics supports a new CPASS Multi-disciplinary Team (MDT) Webinar Series on Medicinal Cannabis

The series commences on November 25th with an expert theory webinar discussion with Dr Anthony Ordman, leading UK Pain Consultant and Senior Clinical Advisor at Integro Clinics and Specialist Cannabis Practise Nurse, Sophie Hayes.

Aimed at nurses and healthcare professionals, this first of a kind series is designed to bring a deeper understanding of medicinal cannabis specifically to the nurse/patient care pathway, in a new MDT approach.

Over the next 12 months, leaders from a multitude of disciplines will come together to provide world class education on medicinal cannabis for UK nurses and healthcare professionals. 

Each event will be structured into 2 parts; the theory behind the benefits of cannabis medicines within key areas of medicine, and the MDT demonstrating how the theory is put into practice. Each MDT will feature a Specialist Consultant, Nurse, GP and Pharmacist, all working within the medicinal cannabis field in the UK.

Their discussion will illustrate real world case studies within each of the following areas; pain, mental health, neurology, oncology, women’s health and palliative care. 

Professor Ann Lloyd Keen, RN NDN FQNI FRCN FAAN, Former Parliamentary Under Secretary of State Health Services, Chair and Co Founder to CPASS Nurses Arm, said: “I have had the good fortune to practice as a registered nurse for approximately 40 years. At the start of my career, the MDT did not exist. Medical hierarchy ruled the day and nurses were never allowed to consider their views as important, despite their role being vital to how patients manage their symptoms.

“This culture was wrong for many reasons but most importantly, the patient did not benefit. Over the decades this has changed for the better, now the MDT is the only way to manage quality safe care with the patient at the centre. 

“It is vital therefore, to firmly establish this framework at the very heart of cannabis-based medicine, not only as a way to ensure appropriate care for patients, but also to illustrate to healthcare professionals how medical cannabis is and can be prescribed in a real world setting.”

This approach is a welcome first for health practitioners in the UK, as medicinal cannabis education expands to reach a more inclusive sector of frontline medics.

Dr Anthony Ordman (pictured), Senior Clinical Adviser and Hon, Medical Director of Integro Medical Clinics and immediate past President of the Pain Medicine Section and of the Royal Society of Medicine said: “This is an exciting time in the evaluation of the roles that cannabis-based medicinal products (CBMPs) can best play in clinical practice.

“We’ve known about the physiological endocannabinoid system for about 30 years now, but we’re only just finding out how to modulate its functions using plant-derived molecules for patient benefit.

“I hope that by sharing understandings and experiences gained from our own journeys with CBMPs, we can help colleagues better understand CBMPs, so they can advise patients who ask about them, and perhaps move towards prescribing themselves.

“At Integro Clinics MDT practise is at the core of our patient centred ethos, ensuring that at all times a gold standard of care is delivered. The input of a multidisciplinary team leads to the best possible outcome for the patient.” 

To join this inaugural seminar on November 25th please register in advance here.

To contact Integro Clinics visit www.integroclinics.com.